About PeptiDream
PeptiDream is a company based in Erimo (Japan) founded in 2006. The company has 621 employees as of December 31, 2024. PeptiDream operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Erimo, Japan
- Employees 621 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Peptidream Inc.
-
Annual Revenue
$297.4 M (USD)62.57as on Dec 31, 2024
-
Net Profit
$95.63 M (USD)394.59as on Dec 31, 2024
-
EBITDA
$150.61 M (USD)146.03as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Gates Foundation
& 1 more
-
Employee Count
621
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PeptiDream
PeptiDream is a publicly listed company on the TSE with ticker symbol 4587 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of PeptiDream
Investors in PeptiDream
PeptiDream has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation and UT-EC Japan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and Early stage VC firm investing in Japan
|
Locked | Locked | Locked | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked |
Investor details for PeptiDream
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PeptiDream
Investment portfolio details for PeptiDream
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PeptiDream
Detailed financials for PeptiDream
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Peptidream Comparisons
Peer comparison for PeptiDream
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PeptiDream
PeptiDream operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of PeptiDream
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Peptidream
Complete news archive for PeptiDream
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PeptiDream
PeptiDream was founded in 2006 and raised its 1st funding round 2 years after it was founded.
PeptiDream is headquartered in Erimo, Japan. It is registered at Erimo, Hokkaido, Japan.
As of Dec 31, 2024, the latest employee count at PeptiDream is 621.
Annual revenue of PeptiDream is $297.4M as on Dec 31, 2024.
PeptiDream was founded in 2006 and is headquartered in Erimo, Japan. Operations focus on the biotechnology sector, where peptide-based therapeutics are created using the proprietary PDPS (Peptide Discovery Platform System) technology. Drug development targets areas including oncology, multiple myeloma, DMD and muscle disorders, influenza, and additional indications, with efforts centered on small molecule solutions for unmet medical needs.
PeptiDream's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Yes, PeptiDream is publicly traded on TSE under the ticker symbol 4587.
PeptiDream has 2 investors. Key investors include Gates Foundation, and UT-EC Japan.
The ticker symbol of PeptiDream is 4587 on TSE.